Evidence map›Paper›PMID 29180823›Full record

ArticleEuropean journal of human genetics : EJHG2018

HUWE1 variants cause dominant X-linked intellectual disability: a clinical study of 21 patients.

Stéphanie Moortgat, Siren Berland, Ingvild Aukrust, Isabelle Maystadt, Laura Baker, Valerie Benoit, Alfonso Caro-Llopis, Nicola S Cooper, François-Guillaume Debray, Laurence Faivre and 23 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Novel HUWE1-Related Neurodevelopmental Disorder: Genotypic and Phenotypic Expansion.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 7 countries.

Stéphanie MoortgatCentre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi (Gosselies), Belgium. stephanie.moortgat@ipg.be.
Siren BerlandCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Ingvild AukrustCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Isabelle MaystadtCentre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi (Gosselies), Belgium.
Laura BakerDepartment of Medical Genetics, Alfred I. duPont Hospital for Children, Wilmington, DE, USA.
Valerie BenoitCentre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi (Gosselies), Belgium.
Alfonso Caro-LlopisUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Nicola S CooperWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
François-Guillaume DebrayDepartment of Medical Genetics, CHU Sart-Tilman, Liège, Belgium.
Laurence FaivreFédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies Du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
Thatjana GardeitchikDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Bjørn I HaukanesCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Gunnar HougeCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Emma KivuvaDepartment of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, EX1 2ED, UK.
Francisco MartinezUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Sarju G MehtaEast Anglian Medical Genetics Service, Cambridge, UK.
Marie-Cécile NassogneDépartement de Neuropédiatrie, Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium.
Nina Powell-HamiltonDepartment of Medical Genetics, Alfred I. duPont Hospital for Children, Wilmington, DE, USA.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Monica RoselloUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Trine PrescottDepartment of Medical Genetics, Telemark Hospital, Skien, Norway.
Pradeep VasudevanDepartment of Clinical Genetics, University Hospitals of Leicester, Leicester, UK.
Barbara van LoonDepartment of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.
Christine Verellen-DumoulinCentre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi (Gosselies), Belgium.
Alain VerloesDepartment of Genetics, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Paris, France.ORCID http://orcid.org/0000-0003-4819-0264
Charlotte von der LippeDepartement of Medical Genetics, Trondheim University Hospital, Trondheim, Norway.
Emma WakelingNorth West Thames Regional Genetics Service, London North West Hospitals NHS Trust, Harrow, UK.
Andrew O M WilkieWeatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2972-5481
Louise WilsonClinical Genetics, Great Ormond Street Hospital for Children NHS foundation Trust, London, UK.
Amy YuenGenomics Institute, MultiCare Health System, Tacoma, WA, USA.
Ddd StudyWellcome Trust Sanger Institute, Cambridgeshire, UK.
Karen J LowUniversity Hospitals Bristol NHS Trust/University of Bristol, Bristol, UK.
Ruth A Newbury-EcobUniversity Hospitals Bristol NHS Trust/University of Bristol, Bristol, UK.
Haukeland University Hospital · NOInstitute of Pathology and Genetics · BEHospital Universitari i Politècnic La Fe · ESAlfred I. duPont Hospital for Children · USRadboud University Nijmegen · NLUniversity Hospitals Bristol NHS Foundation Trust · GBAssistance Publique – Hôpitaux de Paris · FRBirmingham Women’s and Children’s NHS Foundation Trust · GBCliniques Universitaires Saint-Luc · BEFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FRGreat Ormond Street Hospital for Children NHS Foundation Trust · GBLondon North West Healthcare NHS Trust · GBMultiCare Health System · USNorwegian University of Science and Technology · NORoyal Devon and Exeter Hospital · GBSt Olav's University Hospital · NOTelemark Hospital · NOUniversity Hospitals of Leicester NHS Trust · GBUniversity of Oxford · GBWellcome Sanger Institute · GB

Funding

Department of HealthWellcome Trust 102731/Z/13/ZWellcome Trust WT098051
6 · The paper itself

Abstract

Whole-gene duplications and missense variants in the HUWE1 gene (NM_031407.6) have been reported in association with intellectual disability (ID). Increased gene dosage has been observed in males with non-syndromic mild to moderate ID with speech delay. Missense variants reported previously appear to be associated with severe ID in males and mild or no ID in obligate carrier females. Here, we report the largest cohort of patients with HUWE1 variants, consisting of 14 females and 7 males, with 15 different missense variants and one splice site variant. Clinical assessment identified common clinical features consisting of moderate to profound ID, delayed or absent speech, short stature with small hands and feet and facial dysmorphism consisting of a broad nasal tip, deep set eyes, epicanthic folds, short palpebral fissures, and a short philtrum. We describe for the first time that females can be severely affected, despite preferential inactivation of the affected X chromosome. Three females with the c.329 G  >  A p.Arg110Gln variant, present with a phenotype of mild ID, specific facial features, scoliosis and craniosynostosis, as reported previously in a single patient. In these females, the X inactivation pattern appeared skewed in favour of the affected transcript. In summary, HUWE1 missense variants may cause syndromic ID in both males and females.

Indexed as

Genes, DominantAdolescentAdultChildFemaleGenetic Diseases, X-LinkedHumansIntellectual DisabilityMaleMutation, MissenseSyndromeTumor Suppressor ProteinsUbiquitin-Protein LigasesHUWE1 protein, humanTumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID29180823
PMCPMC5788272
OpenAlexW2770515308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.